These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25918068)

  • 1. Glycosylated hemoglobin levels and clinical outcomes in diabetic patients receiving percutaneous coronary interventions: A meta-analysis of cohort studies.
    Xu X; Wang R; Wang Y; Cai S
    Int J Cardiol; 2015; 190():143-7. PubMed ID: 25918068
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
    Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
    Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention.
    Zheng J; Cheng J; Zhang Q; Qi C; Wang T; Xiao X
    Medicine (Baltimore); 2016 May; 95(19):e3696. PubMed ID: 27175711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome.
    Naito R; Miyauchi K; Ogita M; Kasai T; Kawaguchi Y; Tsuboi S; Konishi H; Okazaki S; Kurata T; Daida H
    J Cardiol; 2014 Feb; 63(2):106-11. PubMed ID: 24011926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated hemoglobin at early follow-up and outcome in diabetic patients with ST-segment elevation myocardial infarction.
    Ndrepepa G
    Coron Artery Dis; 2015 Nov; 26(7):551-2. PubMed ID: 26401993
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
    BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glycated hemoglobin on heart function of the patients with revascularization of coronary artery.
    Sun XQ; Bao BN; Gao XY; Yan DE; Zhou YS
    Int J Clin Exp Pathol; 2015; 8(6):7181-8. PubMed ID: 26261612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention.
    Fujiwara T; Yoshida M; Akashi N; Yamada H; Tsukui T; Nakamura T; Sakakura K; Wada H; Arao K; Katayama T; Umemoto T; Funayama H; Sugawara Y; Mitsuhashi T; Kakei M; Momomura S; Ako J
    Heart Vessels; 2016 Jun; 31(6):855-62. PubMed ID: 25921916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
    Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
    Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention.
    Sharma PK; Agarwal S; Ellis SG; Goel SS; Cho L; Tuzcu EM; Lincoff AM; Kapadia SR
    Circ Cardiovasc Interv; 2014 Aug; 7(4):503-9. PubMed ID: 25097197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes and early revascularization on the need for late and repeat procedures.
    Orbach A; Halon DA; Jaffe R; Rubinshtein R; Karkabi B; Flugelman MY; Zafrir B
    Cardiovasc Diabetol; 2018 Feb; 17(1):25. PubMed ID: 29402330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial).
    Tandjung K; van Houwelingen KG; Jansen H; Basalus MW; Sen H; Löwik MM; Stoel MG; Louwerenburg JH; de Man FH; Linssen GC; Nijhuis R; Nienhuis MB; van der Palen J; Stolk RP; von Birgelen C
    Am J Cardiol; 2012 Dec; 110(11):1561-7. PubMed ID: 22939581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
    Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusion.
    Ahn J; Hong TJ; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Cha KS; Yun E; Jeong MH; Chae SC; Kim YJ; Hur SH; Seong IW; Jang YS; Cho MC; Kim CJ; Seung KB; Rha SW; Bae JH; Park SJ;
    Coron Artery Dis; 2015 Nov; 26(7):555-61. PubMed ID: 25933028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
    Hwang JK; Lee SH; Song YB; Ahn J; Carriere K; Jang MJ; Park TK; Choi SH; Yang JH; Choi JH; Lee SH; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28373177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
    von Birgelen C; Kok MM; Sattar N; Zocca P; Doelman C; Kant GD; Löwik MM; van der Heijden LC; Sen H; van Houwelingen KG; Stoel MG; Louwerenburg JHW; Hartmann M; de Man FHAF; Linssen GCM; Doggen CJM; Tandjung K
    JACC Cardiovasc Interv; 2018 Mar; 11(5):448-459. PubMed ID: 29454724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
    Ploumen EH; Buiten RA; Kok MM; Doggen CJM; van Houwelingen KG; Stoel MG; de Man FHAF; Hartmann M; Zocca P; Linssen GCM; Doelman C; Kant GD; von Birgelen C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E110-E118. PubMed ID: 31625262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.